Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 3,582 | 2,703 | 2,344 | 1,549 | 0 |
| Gross Profit | 3,582 | 2,703 | 2,344 | 1,549 | N/A |
| Operating Expenses | 24,888 | 23,447 | 27,654 | 16,159 | 0 |
| Operating Income | -21,306 | -20,744 | -25,310 | -14,610 | N/A |
| Interest Expense | 0 | 0 | -1 | 1 | 0 |
| Other Income | -666 | -452 | 42,807 | -75 | 0 |
| Pre-tax Income | -21,972 | -21,196 | 17,498 | -14,686 | 0 |
| Income Tax | 343 | 279 | 400 | 8 | N/A |
| Net Income Continuous | -22,315 | -21,475 | 17,098 | -14,694 | N/A |
| Minority Interests | N/A | N/A | -1 | -14 | N/A |
| Net Income | $-22,315 | $-21,475 | $17,099 | $-14,680 | $N/A |
| EPS Basic Total Ops | -0.56 | -0.54 | 5.56 | -2.77 | N/A |
| EPS Basic Continuous Ops | -0.56 | -0.54 | 5.56 | -2.78 | N/A |
| EPS Diluted Total Ops | -0.56 | -0.54 | 5.56 | -2.77 | N/A |
| EPS Diluted Continuous Ops | -0.56 | -0.54 | 5.56 | -2.78 | N/A |
| EBITDA(a) | $-20,600 | $-20,024 | $-24,898 | $-14,374 | $N/A |